{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:33:44Z","timestamp":1794645224771,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.6061\/clinics\/2014(01)09","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T05:58:21Z","timestamp":1388123901000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mibefradil reduces blood glucose concentration in db\/db mice"],"prefix":"10.1016","volume":"69","author":[{"given":"Yujie","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3-6","key":"10.6061\/clinics\/2014(01)09_bib1","first-page":"253","article-title":"Role of elevated cytosolic calcium in the pathogenesis of complications in diabetes mellitus","volume":"23","author":"Massry","year":"1997","journal-title":"Miner Electrolyte Metab"},{"issue":"3-4","key":"10.6061\/clinics\/2014(01)09_bib2","first-page":"300","article-title":"Regulation of calcium in pancreatic \u03b1- and \u03b2-cells in health and disease","volume":"51","author":"Roseman","year":"2012","journal-title":"Call Calcium"},{"issue":"3","key":"10.6061\/clinics\/2014(01)09_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0002-9343(94)90152-X","article-title":"Diabetes mellitus: a disease of abnormal cellular calcium metabolism","volume":"96","author":"Levy","year":"1994","journal-title":"Am J Med"},{"key":"10.6061\/clinics\/2014(01)09_bib4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00005344-199106181-00005","article-title":"The future of calcium channel blocker therapy in diabetes mellitus","volume":"18 Suppl 1","author":"Savage","year":"1991","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.6061\/clinics\/2014(01)09_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2840-10-79","volume":"10","author":"Fukao","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.6061\/clinics\/2014(01)09_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cbf.1091","article-title":"Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats","volume":"22","author":"Briede","year":"2004","journal-title":"Cell Biochem Funct"},{"issue":"6","key":"10.6061\/clinics\/2014(01)09_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cbf.1372","article-title":"Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus","volume":"25","author":"Briede","year":"2007","journal-title":"Cell Biochem Funct"},{"key":"10.6061\/clinics\/2014(01)09_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1113\/jphysiol.1987.sp016864","article-title":"Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurons","volume":"394","author":"Fox","year":"1987","journal-title":"J Physiol"},{"key":"10.6061\/clinics\/2014(01)09_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.ph.51.030189.002055","article-title":"Classes of calcium channels in vertebrate cells","volume":"51","author":"Bean","year":"1989","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"10.6061\/clinics\/2014(01)09_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2337\/diab.41.10.1221","article-title":"Electrophysiology of stimulus-secretion coupling in human beta-cells","volume":"41","author":"Misler","year":"1992","journal-title":"Diabetes"},{"issue":"2","key":"10.6061\/clinics\/2014(01)09_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1677\/joe.0.1500195","article-title":"Dihydropyridine-sensitive and -insensitive voltage-operated calcium channels participate in the control of glucose-induced insulin release from human pancreatic beta cells","volume":"150","author":"Davalli","year":"1996","journal-title":"J Endocrinol"},{"issue":"11","key":"10.6061\/clinics\/2014(01)09_bib12","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2337\/diabetes.49.11.1840","article-title":"Glucose-induced [Ca2+]i abnormalities in human pancreatic islets: important role of overstimulation","volume":"49","author":"Bj\u00f6rklund","year":"2000","journal-title":"Diabetes"},{"issue":"suppl","key":"10.6061\/clinics\/2014(01)09_bib13","first-page":"69A","article-title":"High glucose elevated T-type calcium channel expression and basal [Ca2+]i in rat islet beta cells","volume":"78","author":"Zhang","year":"2000","journal-title":"Biophysical J"},{"issue":"3","key":"10.6061\/clinics\/2014(01)09_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)35373-X","article-title":"A mibefradil metabolite is a potent intracellular blocker of L-type Ca(2+) currents in pancreatic beta-cells","volume":"292","author":"Wu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.6061\/clinics\/2014(01)09_bib15","first-page":"417","article-title":"Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension","volume":"40","author":"Hefti","year":"1990","journal-title":"Comparison with verapamil. Arzneimittelforschung"},{"issue":"3 Pt 1","key":"10.6061\/clinics\/2014(01)09_bib16","first-page":"426","article-title":"Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967): a new generation of calcium antagonists","volume":"27","author":"Bernink","year":"1996","journal-title":"Mibefradil International Study Group. Hypertension"},{"issue":"1","key":"10.6061\/clinics\/2014(01)09_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0895-7061(96)00294-4","article-title":"Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries","volume":"10","author":"Li","year":"1997","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.6061\/clinics\/2014(01)09_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1527-3466.1991.tb00539.x","article-title":"Ro 40-5967: A new nondihydropyridine calcium antagonist","volume":"9","author":"Clozel","year":"1991","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"10.6061\/clinics\/2014(01)09_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0008-6363(97)00032-1","article-title":"Chronic T-type Ca<sup>2+<\/sup> channel blockade with mibefradil in hyperinsulinemic, insulin-resistant and hypertensive rats","volume":"34","author":"Verma","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.6061\/clinics\/2014(01)09_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.103.060814","article-title":"NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-Benzimidazol-2-l)propyl]-Nmethylamino) ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A new selective inhibitor of T-type calcium channels","volume":"309","author":"Huang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.6061\/clinics\/2014(01)09_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1527-3466.2005.tb00164.x","article-title":"Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396","volume":"23","author":"Li","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"issue":"5","key":"10.6061\/clinics\/2014(01)09_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.HYP.0000164571.77710.19","article-title":"Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension","volume":"45","author":"Hiyoshi","year":"2005","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"10.6061\/clinics\/2014(01)09_bib23","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322200967X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322200967X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/CLN-69-01\/cln-69-01-061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:56:01Z","timestamp":1761720961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322200967X"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322014000100061&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3870312\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S180759322200967X"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2014(01)09","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mibefradil reduces blood glucose concentration in db\/db mice","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2014(01)09","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}